B-lymphocyte inhibitors (Vivia Biotech)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug NameB-lymphocyte inhibitors (Vivia Biotech)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionB-lymphocyte inhibitors

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVivia Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVivia Biotech

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A